子宫肌瘤 - 维基百科,自由的百科全书
子宫肌瘤 (uterine myoma,hysteromyoma)又称 子宫平滑肌瘤 (uterine leiomyoma),旧称 子宫纤维样瘤[3] (uterine fibroid),是子宫 平滑肌 组织增生而形成的良性肿瘤,其内含有少量 纤维结缔组织,为女性生殖器官中最常见的良性肿瘤。 子宫肌瘤多见于30~50岁女性,常无症状;少数表现为阴道出血、腹部 ...
Searching…
子宫肌瘤 (uterine myoma,hysteromyoma)又称 子宫平滑肌瘤 (uterine leiomyoma),旧称 子宫纤维样瘤[3] (uterine fibroid),是子宫 平滑肌 组织增生而形成的良性肿瘤,其内含有少量 纤维结缔组织,为女性生殖器官中最常见的良性肿瘤。 子宫肌瘤多见于30~50岁女性,常无症状;少数表现为阴道出血、腹部 ...
Feb 25, 2026 · A myoma, also known as a uterine fibroid or a leiomyoma, is a common benign (non-cancerous) tumor that arises in the smooth muscles of the uterus. Myomas can cause symptoms like abdominal pain and heavy...
Dec 15, 2025 · 你是否曾經聽說過「子宮肌瘤」這個名詞?它到底是什麼?會有什麼症狀?又是什麼原因造成的?很多女性朋友可能都有這些疑問。子宮肌瘤雖然常見,但其實很多人對它並不了解。子宮肌瘤前兆?該如何治療?飲食上要注意什麼?這篇文章由婦產科張瑜芹醫師帶你一起來了解!
Jul 22, 2025 · Management and Treatment Pathways Management and treatment of myomas depend on the presence and severity of symptoms, the myoma’s size and location, and the individual’s desire for future fertility. For...
Many people who have uterine fibroids don't have any symptoms. In those who do, symptoms can be influenced by the location, size and number of fibroids. The most common symptoms of uterine fibroids include: Heavy mens...
Sep 3, 2025 · 一、子宮肌瘤是什麼? 子宮肌瘤是女性常見的良性腫瘤之一,是一種由平滑肌細胞和纖維組織組成的良性腫瘤,生長於子宮肌層中,雖然名稱聽起來讓人擔憂,但它並不是癌症,大部分女性在生育年齡階段都有可能出現,子宮肌瘤大小不一,可能像小米粒般細小,也可能長成超過 10 公分的大腫塊 ...
子宮肌瘤是最常見的子宮腫瘤,也是女性骨盆腔內最常見的多發性腫瘤,35歲以上的婦女大約有20~30%的人有此症,實際發生率可能更高。子宮肌瘤是由子宮平滑肌細胞增生而成的良性腫瘤,少數病例也可能由子宮血管壁內之平滑肌所產生。子宮肌瘤的發生原因並不十分清楚,但有人種的差異及家族的 ...
While intramural and subserous myomas can be managed by “watchful waiting,” symptom-oriented treatment, or medical intervention (surgical or nonsurgical), the diagnosis of a submucous myoma as the cause of menorrhagia...
Mar 20, 2026 · What is Uterine Myoma? Uterine myoma, also called fibroid, is a common benign uterine tumor affecting more than 30% of women in their lifetime. Types of Uterine Myoma Uterine myomas can be classified in...
Feb 20, 2025 · What Is Myoma? Myoma, or fibroid,is a common benign uterine tumor which affects about 30% of women.